Sigma Planning Corp’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,383
| Closed | -$12.7K | – | 1202 |
|
|
2023
Q3 | $12.7K | Sell |
1,383
-2,000
| -59% | -$18.3K | ﹤0.01% | 1180 |
|
|
2023
Q2 | $71.5K | Sell |
3,383
-3,429
| -50% | -$72.4K | ﹤0.01% | 1160 |
|
|
2023
Q1 | $183K | Buy |
6,812
+2,935
| +76% | +$79K | 0.01% | 1185 |
|
|
2022
Q4 | $137K | Buy |
3,877
+1,745
| +82% | +$61.8K | ﹤0.01% | 1172 |
|
|
2022
Q3 | $482K | Buy |
2,132
+9
| +0.4% | +$2.04K | 0.02% | 742 |
|
|
2022
Q2 | $401K | Buy |
2,123
+46
| +2% | +$8.69K | 0.01% | 849 |
|
|
2022
Q1 | $517K | Sell |
2,077
-10
| -0.5% | -$2.49K | 0.02% | 827 |
|
|
2021
Q4 | $325K | Buy |
2,087
+49
| +2% | +$7.63K | 0.01% | 1032 |
|
|
2021
Q3 | $408K | Buy |
2,038
+1,506
| +283% | +$301K | 0.01% | 896 |
|
|
2021
Q2 | $136K | Buy |
532
+25
| +5% | +$6.39K | ﹤0.01% | 1319 |
|
|
2021
Q1 | $135K | Hold |
507
| – | – | ﹤0.01% | 1242 |
|
|
2020
Q4 | $187K | Buy |
+507
| New | +$187K | 0.01% | 1100 |
|